Log In | Visit us on: Facebook You Tube
Barth Syndrome Foundation
 
Home | Contact Us | Sitemap |    
  Search  
  Home > Families > Barth Syndrome Registry and Repository

Barth Syndrome Registry and Repository

Barth Syndrome Foundation selected for Global Rare Disease Registry

The Barth Syndrome Foundation (BSF) has been selected as one of thirty-four rare disease organizations to participate in a two-year pilot program of the National Institutes of Health called the Global Rare Disease Registry and Data Repository (GRDR). As a pilot participant, BSF will work in partnership with leaders in rare disease research at the Office of Rare Diseases Research, National Center for Advancing Translational Sciences, National Institutes of Health, PatientCrossroads, Children Hospital of Philadelphia and WebMD. The GRDR program will collect de-identified patient health information from participating registries established by the individual rare disease organizations in order to allow analyses of data across many rare diseases as well as to facilitate clinical trials and other studies.

We are delighted to take part in the pilot program, as research that we have funded for over a decade has made it clear that Barth syndrome, as a multi-system disorder, shares aspects of many other diseases. BSF believes that a collaborative approach is the best way to serve families and, ultimately, to find a specific treatment. Since 2002 BSF has funded 63 peer-reviewed research grants totaling over US $2.3 million, hosts a biennial scientific, medical and family conference, maintains a genetic mutation database for the causative gene of Barth syndrome (tafazzin). We currently have affiliates in Canada, France, the United Kingdom and South Africa.

BSF is dedicated to supporting those with Barth syndrome, their medical professionals, and the scientists who work to understand the disorder. The BSF community has benefitted from the research that has emerged in the last decade, and we expect the GRDR effort to attract even more efforts to test scientific or clinical theories.

About GRDR

Matthew J. Toth, PhD, Principal Investigator
Valerie M. (Shelley) Bowen, Coordinator

Information regarding the Global Rare Disease Registry and Data Repository pilot program is available at http://grdr.info.

Barth Syndrome Registry & Repository (Presentation for National Health Council)
Given by Lindsay Groff, MBA
February 15, 2013

Stay tuned! Please remember to bookmark this page for the most up-to-date information.


Patient Family

If you are a Patient Family and are interested in enrolling your child in the database and/or the DNA Bank, please contact the Principal Investigator, Matthew Toth (mtothbsf[at]comcast.net). This is a wonderful and very valuable way to contribute to Barth syndrome research and to help move knowledge about the disorder forward.

Physician / Researcher

If you are a physician or researcher interested in conducting research using the medical data from the Registry, DNA isolated from patients, or cell lines derived from patients, please consult contact the Principal Investigator, Matthew Toth (mtothbsf[at]comcast.net).


TISSUE BANK ADVISORY COMMITTEE

Carolyn Spencer, MD
Co-Principal Investigator
Pediatric Cardiology
East Carolina University
Greenville, North Carolina

Amy E. Roberts, MD
Co-Principal Investigator
Cardiovascular Genetics Research Program
Children´s Hospital Boston
Boston, Massachusetts
Barry J. Byrne, MD, PhD
Cardiology Director
Department of Pediatrics
Shands Children´s Hospital
University School of Medicine
Gainesville, Florida
Gerald Cox, MD, PhD
Senior Medical Director
Genzyme Corporation
Cambridge, Massachusetts
Richard I. Kelley, MD, PhD
Division of Metabolism
Kennedy Krieger Institute
Johns Hopkins University
Baltimore, Maryland
 
Melissa Maisenbacher, MS, CGC,
   ex-officio
Medical Data Abstraction
University of Florida College of Medicine
Gainesville, Florida
Michael Schlame, MD
Department of Anesthesiology
New York University School of Medicine
New York, New York

Colin G. Steward, FRCP, FRCPCH, PhD
Pediatric Hematology
Royal Hospital for Children
Bristol, England

Matthew J. Toth, PhD
Science Director
Barth Syndrome Foundation, Inc.
Iselin, New Jersey

National Health Council

Disclaimer: BSF does not endorse any drugs, tests, or treatments that we may report. This website is for
informational purposes, always check with your physician before adopting any medical treatment.